Printer Friendly Version

Send to a Friend

New York-based Pfizer began construction in November 2005 on a 330,000-sf expansion of its 900,000-sf Chesterfield, Mo., campus. Slated to open in 2008, the $200-million research and development facility will accommodate approximately 250 employees relocated from other sites engaged in drug research. The four-story building is slated for completion in late 2008 and is being constructed by a joint venture of Gilbane Building Co. and Tarlton Corp.